Use of prostate-specific antigen, gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 379-388

  Rees, M A ^a   Resnick, M I ^a   Oesterling, J E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ASPIRATION BIOPSY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0030929804     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70384-0     Document Type: Article

References (68)

1. D.A. Ackerman J.M. Barry R.A. Wicklund Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy J Urol 150 1993 1845
2. K.H. Benson R.A. Watson D.B. Spring The value of computerized tomography in evaluation of pelvic lymph nodes J Urol 126 1981 63
3. M. Bezzi H.Y. Kressel K.S. Allen Prostatic carcinoma: Staging with MR imaging at 1.5 T Radiology 169 1988 339
4. P.R. Biondetti J.K.T. Lee D. Ling Clinical stage B prostate carcinoma: Staging with MR imaging Radiology 162 1987 325
5. J.T. Bishoff A. Reyes I.M. Thompson Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: Development of a system of patient selection Urology 45 1995 270
6. D.L. Bluestein D.G. Bostwick E.J. Bergstralh Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer J Urol 151 1994 1315
7. C.B. Brendler L.K. Cleeve E.E. Anderson Staging pelvic lymphadenectomy for carcinoma of the prostate: Risk versus benefit J Urol 124 1980 849
8. C.L. Carrol F.G. Sommer J.E. McNeal The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation Radiology 163 1987 521
9. W.J. Catalona D.S. Smith T.L. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 948
10. D.J. Chadwick M. Cobby P. Goddard Comparison of transrectal ultrasound and magnetic resonance imaging in the staging of prostate cancer Br J Urol 67 1991 616
11. A.V. D'Amico R. Whittington M. Schnall The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer Cancer 75 1995 2368
12. R.E. Donohue J.H. Mani J.A. Whitesel Pelvic lymph node dissection: Guide to patient management in clinically locally confined adenocarcinoma of prostate Urology 20 1982 559
13. T. Ebert B.J. Schmitz-Drager K.F. Burrig Accuracy of imaging modalities in staging the local extent of prostate cancer Urol Clin North Am 18 1991 453
14. S.C. Efremidis A. Pagliarul S.J. Dan Post-lymphangiography fine needle aspiration lymph node biopsy in staging carcinoma of the prostate: Preliminary report J Urol 122 1979 495
15. P. Elfving R. Lundgren Pelvic lymphadenectomy as staging before definitive treatment of prostate carcinoma Scand J Urol Nephrol 110 suppl 1988 155
16. T.H. Emory D.B. Reinke A.L. Hill Use of CT to reduce understaging in prostatic cancer: Comparison with conventional staging techniques AJR Am J Roentgenol 141 1983 351
17. R.C. Flanigan J.L. Mohler C.T. King Preoperative lymph node evaluation in prostatic cancer patients who are surgical candidates: The role of lymphangiography and computerized tomography scanning with directed fine needle aspiration J Urol 134 1985 84
18. G.R. Fournier P. Narayan Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer Br J Urol 72 1993 484
19. A.C. Friedman E.J. Seidmon P.D. Radecki Relative merits of MRI, transrectal endosonography and CT in diagnosis and staging of carcinoma of prostate Urology 31 1988 530
20. W.F. Gee L. Holtgrewe P.C. Albertsen Practice trends in the diagnosis and management of prostate cancer in the United States J Urol 154 1995 207
21. M. Golimbu P. Morales S. Al-Askari CAT scanning in staging of prostatic cancer Urology 18 1981 305
22. F.J. Greskovich D.E. Johnson D.M. Tenney Prostate specific antigen in patients with clinical stage C prostate cancer: Relation to lymph node status and grade J Urol 145 1991 798
23. G.E. Hanks J.M. Krall M.V. Pilepich Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: Implications of RTOG data for patient management and trial design and statification Int J Radiat Oncol Biol Phys 23 1992 293
24. S.T. Houston L.W. Jones V. Waluch Nuclear magnetic resonance imaging in detecting and staging prostatic cancer Urology 31 1988 171
25. H. Hricak G.C. Domms R.B. Jeffrey Prostatic carcinoma: Staging by clinical assessment, CT, and MR imaging Radiology 162 1987 331
26. R.A. Huch Boni J.A. Boner U.M. Lutolf Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma J Comput Assist Tomogr 19 1995 232
27. H. Huland P. Hammerer R.P. Henke Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies J Urol 155 1996 1344
28. L.R. Kavoussi Techniques for nodal staging in prostate cancer [editorial] J Urol 151 1994 1324
29. E. Kleer J.J. Larson-Keller H. Zincke Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy: Influence of clinical stage and tumor grade Urology 41 1993 207
30. S.A. Kramer J. Spahr C.B. Brendler Experience with Gleason's histopathologic grading in prostatic cancer J Urol 124 1980 223
31. P.H. Lange C.J. Ercole D.J. Lightner The value of serum prostate specific antigen determinations before and after radical prostatectomy J Urol 141 1989 873
32. J.K.T. Lee R.J. Stanley S.S. Sagel Accuracy of CT in detecting intra-abdominal and pelvic lymph node metastases from pelvic cancers AJR Am J Roentgenol 131 1978 675
33. M.S. Levine P.H. Arger B.G. Coleman Detecting lymphatic metastases from prostatic carcinoma: Superiority of CT AJR Am J Roentgenol 137 1981 207
34. A. Levran J.A. Gonzalez A.C. Diokno Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 75 1995 778
35. C. Mettlin G.P. Murphy F. Lee Characteristics of prostate cancers detected in a multimodality early detection program: The Investigators of the American Cancer Society—National Prostate Cancer Detection Project Cancer 72 1993 1701
36. W.R. Morgan M.M. Lieber Pelvic lymphadenectomy Crawford E.D. Das S. Current Genitourinary Cancer Surgery 1990 Lea & Febiger Philadelphia 162 169
37. E. Mukamel J. Hannah Z. Barbaric The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: Comparison with the clinical and histological staging J Urol 136 1986 1231
38. P. Narayan V. Gajendran S.P. Taylor The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer Urology 46 1995 205
39. J.E. Oesterling D.W. Chan J.I. Epstein Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J Urol 139 1988 766
40. M. Ohori K. Shinohara T.M. Wheeler Ultrasonic detection of nonpalpable seminal vesicle invasion: A clinicopathological study Br J Urol 72 1993 799
41. S.L. Parker T. Tong S. Bolden Cancer statistics, 1996 CA 46 1996 5
42. A.W. Partin P.C. Walsh Letters to the editor, re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 152 1994 172
43. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
44. A.W. Partin J. Yoo H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110
45. J.A. Petros W.J. Catalona Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer J Urol 147 1992 1574
46. J.F. Platt R.L. Bree R.E. Schwab The accuracy of CT in the staging of prostatic carcinoma AJR Am J Roentgenol 149 1987 315
47. V. Ravery L.A. Bocon-Gibod M.C. Dauge-Geffroy Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy Urology 44 1994 371
48. M.A. Rees T.A. McHugh R.P. Dorr Assessment of the utility of bone scan, CT scan and lymph node dissection in staging of patients with newly diagnosed prostate cancer [abstract 495] J Urol 153 1995 352A
49. M.A. Rees A.W. Partin S.C. Campbell Validation of a model for predicting metastatic disease in the pelvic lymph nodes of patients with clinically localized prostate cancer [abstract 707] J Urol 155 1996 487A
50. M.D. Rifkin E.A. Zerhouni C.A. Gatsonis Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer N Engl J Med 323 1990 621
51. M. Roach III C. Marquez Y. Hae-Sook Predicting the risk of lymph node involvement using pretreatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1993 333
52. A.I. Sagalowsky H. Milam L.R. Reveley Prediction of lymphatic metastases by gleason histologic grading in prostatic cancer J Urol 128 1982 951
53. J.O. Salo L. Kivisaari S. Rannikkoo Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy J Urol 137 1987 435
54. M.E. Sands G.K. Zagars A. Pollack Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer Urology 44 1994 215
55. M.L. Schiebler B.C. Yankaskas C. Tempany Efficacy of prostate-specific antigen and magnetic resonance imaging in staging stage C adenocarcinoma of the prostate Invest Radiol 27 1992 575
56. M.D. Schnall Y. Imai J. Tomaszewski Prostate cancer: Local staging with endorectal surface coil MR imaging Radiology 178 1991 797
57. E.K. Seaman I.S. Whang W. Cooner Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate Urology 43 1994 645
58. J.A. Smith J.P. Seaman J.B. Gleidman Pelvic lymph node metastasis from prostatic cancer: Influence of tumor grade and stage in 452 consecutive patients J Urol 130 1983 290
59. J.P. Spirnak M.I. Resnick Clinical staging of prostatic cancer: New modalities Urol Clin North Am 11 1984 221
60. T.A. Stamey J.E. McNeal Adenocarcinoma of the prostate Walsh P.C. Retik A.B. Stamey T.A. Campbell's Urology ed 6 1992 WB Saunders Philadelphia 1159 1122
61. T.A. Stamey J.N. Kabalin J.E. McNeal Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate: II. Radical prostatectomy treated patients J Urol 141 1989 1076
62. R.J. Sukov P.T. Scardino W.F. Sample Computed tomography and transabdominal ultrasound in the evaluation of the prostate J Comput Assist Tomogr 1 1977 281
63. C.M. Tempany X. Zhou E.A. Zerhouni Staging of prostate cancer: Results of radiology diagnostic oncology group project comparison of three MR imaging techniques Radiology 192 1994 47
64. H. Van Poppel F. Ameye R. Oyen Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma J Urol 151 1994 1310
65. A. Wajsman M. Gamarra J.J. Park Transabdominal fine needle aspiration of retroperitoneal lymph nodes in staging of genitourinary tract cancer (correlation with lymphography and lymph node dissection findings) J Urol 128 1982 1238
66. H.N. Winfield Laparoscopy in urology Urology Times 21 1993 6
67. A.L. Zietman R.A. Edelstein J.J. Coen Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome Urology 43 1994 828
68. H. Zincke G.M. Farrow R.P. Myers Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases J Urol 128 1982 498